IL17A Polyclonal Antibody

IL17A

IL17A,also named as IL-17,is a proinflammatory cytokine. IL-17,synthesized only by memory T cells and natural killer cells,has pleiotropic effects,mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2),as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis,psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein,that is widely expressed on epithelial cells,fibroblasts,B and T cells,and monocytic cells. In psoriatic skin lesions,both Th17 cells and their downstream effector molecules,e.g. IL-17 and IL-22,are highly increased.

PBS with 0.05% NaN3 and 40% Glycerol,pH7.4

1.14 mg/mL

Unconjugated

IHC 1:30-1:150, ELISA 1:5000-1:10000

Synthetic peptide of human IL17A

Antigen affinity purification

CTLA 8;CTLA-8;CTLA8;Cytotoxic T lymphocyte associated antigen 8;Cytotoxic T lymphocyte associated protein 8;Cytotoxic T lymphocyte associated serine esterase 8;Cytotoxic T-lymphocyte-associated antigen 8;IL 17A;IL-17;IL-17A;IL17;IL17;Il17a;Interleukin 17 (cytotoxic T lymphocyte associated serine esterase 8);Interleukin 17A;Interleukin-17A;Interleukin17;Interleukin17A;OTTHUMP00000016597;OTTMUSP00000046003

Q16552